Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MEMS
1651
DELISTED
MEMSIC INC COM STK (DE)
MEMS
| $1.75M | ﹤0.01% |
+428,100
| New | +$1.61M |
|
|
AGN
1652
DELISTED
Allergan plc
AGN
| $1.75M | ﹤0.01% |
+13,864
| New | +$1.57M |
|
1653
Quaker Houghton
KWR
$2.58B
| $1.75M | ﹤0.01% |
+28,200
| New | +$1.74M |
|
|
OPLK
1654
DELISTED
OPLINK COMMUNICATIONS INC
OPLK
| $1.74M | ﹤0.01% |
+100,285
| New | +$1.69M |
|
|
JMBA
1655
DELISTED
Jamba, Inc.
JMBA
| $1.74M | ﹤0.01% |
+116,580
| New | +$1.72M |
|
1656
Hyster-Yale Materials Handling
HY
$576M
| $1.74M | ﹤0.01% |
+27,670
| New | +$1.63M |
|
1657
Harvard Bioscience
HBIO
$27.6M
| $1.73M | ﹤0.01% |
+48,671
| New | +$1.86M |
|
|
SMA
1658
DELISTED
SYMMETRY MEDICAL INC
SMA
| $1.73M | ﹤0.01% |
+205,900
| New | +$2.12M |
|
|
BSQR
1659
DELISTED
BSQUARE Corporation
BSQR
| $1.73M | ﹤0.01% |
+630,075
| New | +$1.83M |
|
1660
Cathay General Bancorp
CATY
$4.23B
| $1.72M | ﹤0.01% |
+84,571
| New | +$1.67M |
|
1661
Global Ship Lease
GSL
$1.56B
| $1.71M | ﹤0.01% |
+53,775
| New | +$1.87M |
|
|
SRT
1662
DELISTED
Startek Inc.
SRT
| $1.71M | ﹤0.01% |
+361,700
| New | +$2.02M |
|
|
EAC
1663
DELISTED
Erickson Incorporated
EAC
| $1.71M | ﹤0.01% |
+90,900
| New | +$1.96M |
|
1664
Vicor
VICR
$8.33B
| $1.71M | ﹤0.01% |
+249,400
| New | +$1.34M |
|
|
DOLE
1665
DELISTED
DOLE FOOD CO INC NEW CMN STK (DE)
DOLE
| $1.71M | ﹤0.01% |
+133,700
| New | +$1.47M |
|
1666
Comp X International
CIX
$352M
| $1.7M | ﹤0.01% |
+121,600
| New | +$1.47M |
|
1667
FNB Corp
FNB
$6.76B
| $1.7M | ﹤0.01% |
+140,474
| New | +$1.62M |
|
1668
Methode Electronics
MEI
$458M
| $1.7M | ﹤0.01% |
+99,780
| New | +$1.45M |
|
1669
Transact Technologies
TACT
$50.5M
| $1.7M | ﹤0.01% |
+207,600
| New | +$1.62M |
|
|
SAFM
1670
DELISTED
Sanderson Farms Inc
SAFM
| $1.69M | ﹤0.01% |
+25,500
| New | +$1.61M |
|
1671
Progressive
PGR
$128B
| $1.69M | ﹤0.01% |
+66,600
| New | +$1.68M |
|
1672
Covenant Logistics
CVLG
$1.04B
| $1.69M | ﹤0.01% |
+540,400
| New | +$1.54M |
|
|
GIVN
1673
DELISTED
GIVEN IMAGING LTD
GIVN
| $1.69M | ﹤0.01% |
+120,299
| New | +$1.83M |
|
|
EDMC
1674
DELISTED
EDUCATION MGMT CORP NEW COM STK (PA)
EDMC
| $1.68M | ﹤0.01% |
+298,100
| New | +$1.74M |
|
1675
HealthStream
HSTM
$863M
| $1.67M | ﹤0.01% |
+66,000
| New | +$1.59M |
|
Similar funds
Renaissance Technologies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.